Page last updated: 2024-09-03

dl 111-it and Cancer of Prostate

dl 111-it has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arseni, B; Campo, S; D'Alessio, V; De Santis, R; Loiarro, M; Rossi, S; Ruggiero, V; Sette, C	1
Fang, RY; He, QJ; Lou, YJ; Yang, B	1

Other Studies

2 other study(ies) available for dl 111-it and Cancer of Prostate

Article	Year
Anti-proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down-regulation of cyclin and androgen receptor expression. The Prostate, 2011, Jan-01, Volume: 71, Issue:1 Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Cyclins; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunosuppressive Agents; Male; Prostatic Neoplasms; Receptors, Androgen; Triazoles	2011
Contragestazol (DL111-IT) inhibits proliferation of human androgen-independent prostate cancer cell line PC3 in vitro and in vivo. Asian journal of andrology, 2005, Volume: 7, Issue:4 Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Dose-Response Relationship, Drug; Female; G1 Phase; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Resting Phase, Cell Cycle; Retinoblastoma Protein; Transplantation, Heterologous; Triazoles	2005

Article

Year

Anti-proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down-regulation of cyclin and androgen receptor expression.

The Prostate, 2011, Jan-01, Volume: 71, Issue:1

Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Cyclins; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunosuppressive Agents; Male; Prostatic Neoplasms; Receptors, Androgen; Triazoles

2011

Contragestazol (DL111-IT) inhibits proliferation of human androgen-independent prostate cancer cell line PC3 in vitro and in vivo.

Asian journal of andrology, 2005, Volume: 7, Issue:4

Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Dose-Response Relationship, Drug; Female; G1 Phase; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Resting Phase, Cell Cycle; Retinoblastoma Protein; Transplantation, Heterologous; Triazoles

2005